Ophthalmic Drug Development Program

Due to our unique and extensive experience in ophthalmology, experts at Iris Pharma have the knowledge and expertise to guide new ophthalmic products and medical devices through the development process, from preclinical efficacy in animal models to phase 4 clinical trials. Our dedicated experts across all of our services make sure that the preclinical development program supports and respects the intended clinical trial design and therapeutic use. As a partner, we help you to make the right decisions to develop successful ocular drugs and devices in the most cost-effective and efficient manner.

If you have a question related to your drug development program, are seeking a consultant for strategic or global drug development, or are interested in meeting or training with us, our experts may be able to help you.